Skip to main content

Table 1 Correlation between LCN2 expression and clinicopathologic parameters in NSCLC patients. *P < 0.05

From: Lipocalin-2 promotes NSCLC progression by activating the JAK2/STAT3 signaling pathway

 

Variables

LCN2 expression

Total

χ 2

P value

  

high

low

   

Sex

    

4.130

0.042*

 

Female

10

10

20

  
 

male

19

5

24

  

Age (year)

    

3.334

0.068

 

< 65

14

3

17

  
 

≥ 65

15

12

27

  

T stage

    

2.276

0.131

 

T1/T2

25

15

40

  
 

T3/ T4

4

0

4

  

N stage

    

4.306

0.038*

 

N0/Nx

22

15

37

  
 

N1/N2/N3

7

0

7

  

M stage

    

0.529

0.467

 

M0

28

15

43

  
 

M1

1

0

1

  

TNM stage

    

2.918

0.088

 

I/ II

24

15

39

  
 

III/IV

5

0

5

  
  1. *P < 0.05
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us